FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313825863> ?p ?o ?g. }

• W4313825863 abstract "Idiopathic multicentric Castleman disease (iMCD) is a systemic and polyclonal lymphoproliferative disease involving multiple organs, including the kidneys, due to the overproduction of interleukin-6 (IL-6). Recently, several reports have suggested that excessive IL-6 actions in iMCD could have a causal relationship with the development of diverse histopathological renal manifestations that cause nephrotic syndrome. However, the treatment for such cases remains unclear. We report a series of three cases of nephrotic syndrome due to iMCD that helps to delineate the importance of early and continuous therapy with the anti-interleukin-6 receptor antibody tocilizumab. First, treatment was suspended for infectious control, and the patient presented with nephrotic syndrome due to diffuse mesangial and endocapillary hypercellularity without immune deposits complicating acute kidney injury. Second, iMCD was treated with prednisolone alone. The patient suddenly developed nephrotic syndrome due to immune-complex glomerulonephritis, not otherwise specified, complicated with acute kidney injury. In the third case, nephrotic syndrome secondary to membranous glomerulonephritis was diagnosed, with a skin rash and IgE antibodies to tocilizumab, and was therefore treated with prednisolone alone. In contrast to the first two cases, the third progressed to end-stage renal disease on hemodialysis. Taken together, this series suggests that clinicians should maintain clinical vigilance for iMCD as a possible underlying component of nephrotic syndrome, since iMCD presents with a variety of renal pathologies. Prompt initiation and continuous administration of tocilizumab are likely key determinants of renal outcomes in such cases. In particular, when tocilizumab is suspended due to infection or in the perioperative period, consideration of its expeditious resumption should be made, taking into account both the withdrawal period and systemic conditions." @default.
• W4313825863 created "2023-01-09" @default.
• W4313825863 creator A5004640711 @default.
• W4313825863 creator A5006497339 @default.
• W4313825863 creator A5007582156 @default.
• W4313825863 creator A5012571112 @default.
• W4313825863 creator A5014081695 @default.
• W4313825863 creator A5031471451 @default.
• W4313825863 creator A5036732670 @default.
• W4313825863 creator A5038395215 @default.
• W4313825863 creator A5039255599 @default.
• W4313825863 creator A5048318285 @default.
• W4313825863 creator A5062910998 @default.
• W4313825863 creator A5071318342 @default.
• W4313825863 creator A5077263580 @default.
• W4313825863 creator A5077665206 @default.
• W4313825863 creator A5085905303 @default.
• W4313825863 creator A5089522090 @default.
• W4313825863 date "2023-01-09" @default.
• W4313825863 modified "2023-09-26" @default.
• W4313825863 title "Case report: Importance of early and continuous tocilizumab therapy in nephrotic syndrome associated with idiopathic multicentric Castleman disease: A case series" @default.
• W4313825863 cites W1632068222 @default.
• W4313825863 cites W1924124676 @default.
• W4313825863 cites W1969202687 @default.
• W4313825863 cites W1972639604 @default.
• W4313825863 cites W1987091861 @default.
• W4313825863 cites W2023761225 @default.
• W4313825863 cites W2028031291 @default.
• W4313825863 cites W2029914290 @default.
• W4313825863 cites W2046516518 @default.
• W4313825863 cites W2060912271 @default.
• W4313825863 cites W2086535745 @default.
• W4313825863 cites W2139234229 @default.
• W4313825863 cites W2150642904 @default.
• W4313825863 cites W2150893441 @default.
• W4313825863 cites W2153798731 @default.
• W4313825863 cites W2165088734 @default.
• W4313825863 cites W2169031812 @default.
• W4313825863 cites W2171799063 @default.
• W4313825863 cites W2179940598 @default.
• W4313825863 cites W2292515486 @default.
• W4313825863 cites W2296827990 @default.
• W4313825863 cites W2307606918 @default.
• W4313825863 cites W2314660455 @default.
• W4313825863 cites W2586251631 @default.
• W4313825863 cites W2586608655 @default.
• W4313825863 cites W2751966399 @default.
• W4313825863 cites W2768411519 @default.
• W4313825863 cites W2769119102 @default.
• W4313825863 cites W2890680400 @default.
• W4313825863 cites W2897062932 @default.
• W4313825863 cites W2902760866 @default.
• W4313825863 cites W2999294885 @default.
• W4313825863 cites W3006713791 @default.
• W4313825863 cites W3044064362 @default.
• W4313825863 cites W3088952690 @default.
• W4313825863 cites W3098207754 @default.
• W4313825863 cites W3148486787 @default.
• W4313825863 cites W3155992812 @default.
• W4313825863 cites W3157131991 @default.
• W4313825863 cites W3182651380 @default.
• W4313825863 cites W3191944886 @default.
• W4313825863 cites W4200600251 @default.
• W4313825863 cites W4234924147 @default.
• W4313825863 cites W4284890864 @default.
• W4313825863 doi "https://doi.org/10.3389/fmed.2022.1037032" @default.
• W4313825863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36698794" @default.
• W4313825863 hasPublicationYear "2023" @default.
• W4313825863 type Work @default.
• W4313825863 citedByCount "0" @default.
• W4313825863 crossrefType "journal-article" @default.
• W4313825863 hasAuthorship W4313825863A5004640711 @default.
• W4313825863 hasAuthorship W4313825863A5006497339 @default.
• W4313825863 hasAuthorship W4313825863A5007582156 @default.
• W4313825863 hasAuthorship W4313825863A5012571112 @default.
• W4313825863 hasAuthorship W4313825863A5014081695 @default.
• W4313825863 hasAuthorship W4313825863A5031471451 @default.
• W4313825863 hasAuthorship W4313825863A5036732670 @default.
• W4313825863 hasAuthorship W4313825863A5038395215 @default.
• W4313825863 hasAuthorship W4313825863A5039255599 @default.
• W4313825863 hasAuthorship W4313825863A5048318285 @default.
• W4313825863 hasAuthorship W4313825863A5062910998 @default.
• W4313825863 hasAuthorship W4313825863A5071318342 @default.
• W4313825863 hasAuthorship W4313825863A5077263580 @default.
• W4313825863 hasAuthorship W4313825863A5077665206 @default.
• W4313825863 hasAuthorship W4313825863A5085905303 @default.
• W4313825863 hasAuthorship W4313825863A5089522090 @default.
• W4313825863 hasBestOaLocation W43138258631 @default.
• W4313825863 hasConcept C126322002 @default.
• W4313825863 hasConcept C159654299 @default.
• W4313825863 hasConcept C203014093 @default.
• W4313825863 hasConcept C2776715498 @default.
• W4313825863 hasConcept C2777178219 @default.
• W4313825863 hasConcept C2778930706 @default.
• W4313825863 hasConcept C2779134260 @default.
• W4313825863 hasConcept C2780091579 @default.
• W4313825863 hasConcept C2780368995 @default.
• W4313825863 hasConcept C2780472472 @default.
• W4313825863 hasConcept C2780653079 @default.
• W4313825863 hasConcept C71924100 @default.

• next